FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2110367866> ?p ?o ?g. }

• W2110367866 endingPage "5194" @default.
• W2110367866 startingPage "5190" @default.
• W2110367866 abstract "Abstract Cathepsin D is an aspartyl protease involved in protein catabolism and tissue remodeling which can be secreted from cancer cells. To identify a potential serum marker for gliomas, we investigated the gene expression levels of cathepsin D in 87 tissue samples and measured the protein concentrations in sera of glioma patients. The tissue samples consisted of 43 glioblastomas, 13 anaplastic astrocytomas, 22 astrocytomas, and 9 normal brain tissues. The results of real-time quantitative reverse transcription-PCR analysis showed that cathepsin D transcript levels became significantly higher as the glioma grade advanced (P = 0.0466, glioblastoma and anaplastic astrocytoma; P = 0.0008, glioblastoma and astrocytoma; P = 0.0271, glioblastoma and normal brain tissue; unpaired t test). Immunohistochemical analysis with anti-cathepsin D antibody revealed dense and spotty staining in the tumor cells with high transcript levels. The low expression of cathepsin D significantly correlated with long survival of the glioma patients. Furthermore, the glioblastoma patients with high gene expression of cathepsin D lived significantly shorter than those with low expression (P = 0.0104, Cox-Mantel log-rank test) and frequently had leptomeningeal dissemination (P = 0.0016, χ2 test). The multivariate analysis confirmed that the cathepsin D expression level was an independent predictor for short survival (P = 0.0102, Cox proportional hazard regression model). Measurement of the serum cathepsin D concentrations by ELISA showed a significant increase in the patients with high-grade gliomas as compared with the low-grade tumors (P = 0.0081, χ2 test). These results collectively suggest that cathepsin D could be a potential serum marker for the prediction of aggressive nature of human gliomas." @default.
• W2110367866 created "2016-06-24" @default.
• W2110367866 creator A5023371050 @default.
• W2110367866 creator A5039823293 @default.
• W2110367866 creator A5045590898 @default.
• W2110367866 creator A5051059907 @default.
• W2110367866 creator A5056869794 @default.
• W2110367866 creator A5076049165 @default.
• W2110367866 creator A5081622324 @default.
• W2110367866 creator A5082329874 @default.
• W2110367866 creator A5084473935 @default.
• W2110367866 creator A5090365310 @default.
• W2110367866 date "2005-06-15" @default.
• W2110367866 modified "2023-10-14" @default.
• W2110367866 title "Cathepsin D Is a Potential Serum Marker for Poor Prognosis in Glioma Patients" @default.
• W2110367866 cites W1519534578 @default.
• W2110367866 cites W1560487523 @default.
• W2110367866 cites W1994567037 @default.
• W2110367866 cites W2003122962 @default.
• W2110367866 cites W2009509539 @default.
• W2110367866 cites W2020832719 @default.
• W2110367866 cites W2028524759 @default.
• W2110367866 cites W2031240430 @default.
• W2110367866 cites W2033558282 @default.
• W2110367866 cites W2036408537 @default.
• W2110367866 cites W2047566735 @default.
• W2110367866 cites W2075708253 @default.
• W2110367866 cites W2090951668 @default.
• W2110367866 cites W2115786720 @default.
• W2110367866 cites W2156094924 @default.
• W2110367866 cites W2157586663 @default.
• W2110367866 doi "https://doi.org/10.1158/0008-5472.can-04-4134" @default.
• W2110367866 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15958563" @default.
• W2110367866 hasPublicationYear "2005" @default.
• W2110367866 type Work @default.
• W2110367866 sameAs 2110367866 @default.
• W2110367866 citedByCount "99" @default.
• W2110367866 countsByYear W21103678662012 @default.
• W2110367866 countsByYear W21103678662013 @default.
• W2110367866 countsByYear W21103678662014 @default.
• W2110367866 countsByYear W21103678662015 @default.
• W2110367866 countsByYear W21103678662016 @default.
• W2110367866 countsByYear W21103678662017 @default.
• W2110367866 countsByYear W21103678662018 @default.
• W2110367866 countsByYear W21103678662019 @default.
• W2110367866 countsByYear W21103678662020 @default.
• W2110367866 countsByYear W21103678662021 @default.
• W2110367866 countsByYear W21103678662022 @default.
• W2110367866 countsByYear W21103678662023 @default.
• W2110367866 crossrefType "journal-article" @default.
• W2110367866 hasAuthorship W2110367866A5023371050 @default.
• W2110367866 hasAuthorship W2110367866A5039823293 @default.
• W2110367866 hasAuthorship W2110367866A5045590898 @default.
• W2110367866 hasAuthorship W2110367866A5051059907 @default.
• W2110367866 hasAuthorship W2110367866A5056869794 @default.
• W2110367866 hasAuthorship W2110367866A5076049165 @default.
• W2110367866 hasAuthorship W2110367866A5081622324 @default.
• W2110367866 hasAuthorship W2110367866A5082329874 @default.
• W2110367866 hasAuthorship W2110367866A5084473935 @default.
• W2110367866 hasAuthorship W2110367866A5090365310 @default.
• W2110367866 hasBestOaLocation W21103678661 @default.
• W2110367866 hasConcept C121608353 @default.
• W2110367866 hasConcept C126322002 @default.
• W2110367866 hasConcept C142724271 @default.
• W2110367866 hasConcept C167844969 @default.
• W2110367866 hasConcept C173633252 @default.
• W2110367866 hasConcept C181199279 @default.
• W2110367866 hasConcept C204232928 @default.
• W2110367866 hasConcept C2778227246 @default.
• W2110367866 hasConcept C2778880634 @default.
• W2110367866 hasConcept C2779083369 @default.
• W2110367866 hasConcept C2780034444 @default.
• W2110367866 hasConcept C28021979 @default.
• W2110367866 hasConcept C502942594 @default.
• W2110367866 hasConcept C55493867 @default.
• W2110367866 hasConcept C71924100 @default.
• W2110367866 hasConcept C86803240 @default.
• W2110367866 hasConceptScore W2110367866C121608353 @default.
• W2110367866 hasConceptScore W2110367866C126322002 @default.
• W2110367866 hasConceptScore W2110367866C142724271 @default.
• W2110367866 hasConceptScore W2110367866C167844969 @default.
• W2110367866 hasConceptScore W2110367866C173633252 @default.
• W2110367866 hasConceptScore W2110367866C181199279 @default.
• W2110367866 hasConceptScore W2110367866C204232928 @default.
• W2110367866 hasConceptScore W2110367866C2778227246 @default.
• W2110367866 hasConceptScore W2110367866C2778880634 @default.
• W2110367866 hasConceptScore W2110367866C2779083369 @default.
• W2110367866 hasConceptScore W2110367866C2780034444 @default.
• W2110367866 hasConceptScore W2110367866C28021979 @default.
• W2110367866 hasConceptScore W2110367866C502942594 @default.
• W2110367866 hasConceptScore W2110367866C55493867 @default.
• W2110367866 hasConceptScore W2110367866C71924100 @default.
• W2110367866 hasConceptScore W2110367866C86803240 @default.
• W2110367866 hasIssue "12" @default.
• W2110367866 hasLocation W21103678661 @default.
• W2110367866 hasLocation W21103678662 @default.
• W2110367866 hasOpenAccess W2110367866 @default.
• W2110367866 hasPrimaryLocation W21103678661 @default.

• next